Market Overview

UPDATE: Imperial Capital Initiates Crocs at Outperform on Valuation and Outlook

Related CROX
Earnings Scheduled For March 1, 2017
Mid-Afternoon Market Update: Gold Futures Down 3.5%; PTC Therapeutics Shares Spike Higher

Imperial Capital initiated coverage on Crocs (NASDAQ: CROX) with an Outperform rating and a $16 price target.

Imperial Capital commented, "We believe Crocs is well positioned to generate sales and EBITDA growth in the 15%+ range over the coming years given continued efforts to broaden its product assortment, aggressively grow its specialty retail store footprint, further develop its internet business, and move into new geographies globally. In our view, valuation looks attractive with the stock trading at a significant discount to its peers and its historical average. Near-term risks include the difficult external environment in Japan and Europe which could limit upside to earnings in 2013."

Crocs closed at $13.30 on Wednesday.

Latest Ratings for CROX

Nov 2016Monness Crespi HardtDowngradesBuyNeutral
Aug 2016SusquehannaInitiates Coverage onNeutral
May 2016Sterne Agee CRTUpgradesNeutralBuy

View More Analyst Ratings for CROX
View the Latest Analyst Ratings

Posted-In: imperial capitalAnalyst Color Initiation Intraday Update Analyst Ratings


Related Articles (CROX)

View Comments and Join the Discussion!